Compare Stocks: ALM, KOPN, and CGEM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALM Almonty Industries	$9.16 +3.5%	$14.33	$5.43 ▼ $24.41	$2.64B	4.15	5.87 million shs	2.85 million shs
CGEM Cullinan Therapeutics	$14.64 +1.9%	$18.55	$6.73 ▼ $23.19	$939.33M	-0.05	897,855 shs	93,004 shs
KOPN Kopin	$3.48 +2.8%	$4.45	$1.81 ▼ $6.61	$645.90M	3.59	5.08 million shs	1.08 million shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALM Almonty Industries	0.00%	-9.97%	-35.50%	-33.71%	+27.34%
CGEM Cullinan Therapeutics	0.00%	+11.14%	-2.97%	-17.56%	+85.18%
KOPN Kopin	0.00%	+2.74%	-32.26%	-8.89%	-10.82%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALM Almonty Industries	$9.16 +3.5%	$14.33	$5.43 ▼ $24.41	$2.64B	4.15	5.87 million shs	2.85 million shs
CGEM Cullinan Therapeutics	$14.64 +1.9%	$18.55	$6.73 ▼ $23.19	$939.33M	-0.05	897,855 shs	93,004 shs
KOPN Kopin	$3.48 +2.8%	$4.45	$1.81 ▼ $6.61	$645.90M	3.59	5.08 million shs	1.08 million shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALM Almonty Industries	0.00%	-9.97%	-35.50%	-33.71%	+27.34%
CGEM Cullinan Therapeutics	0.00%	+11.14%	-2.97%	-17.56%	+85.18%
KOPN Kopin	0.00%	+2.74%	-32.26%	-8.89%	-10.82%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALM Almonty Industries	2.88	Moderate Buy	$23.54	164.81% Upside
CGEM Cullinan Therapeutics	2.78	Moderate Buy	$33.71	126.77% Upside
KOPN Kopin	2.63	Moderate Buy	$7.17	111.09% Upside

Current Analyst Ratings Breakdown

Latest ALM, KOPN, and CGEM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/23/2026	KOPN Kopin	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold (C-) ➝ Sell (D+)
10/20/2026	ALM Almonty Industries	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$25.00 ➝ $21.00
10/19/2026	CGEM Cullinan Therapeutics	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$40.00
10/8/2026	KOPN Kopin	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (D+) ➝ Hold (C-)
10/2/2026	CGEM Cullinan Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/2/2026	CGEM Cullinan Therapeutics	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$35.00
9/25/2026	ALM Almonty Industries	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C-) ➝ Hold (C)
9/25/2026	KOPN Kopin	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$6.50
9/25/2026	CGEM Cullinan Therapeutics	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$30.00 ➝ $35.00
9/25/2026	ALM Almonty Industries	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$25.00
9/25/2026	CGEM Cullinan Therapeutics	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$40.00

(Data available from 10/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALM Almonty Industries	$85.80M	29.85	N/A	N/A	$0.97 per share	9.16
CGEM Cullinan Therapeutics	N/A	N/A	N/A	N/A	$6.92 per share	N/A
KOPN Kopin	$39.32M	16.05	$0.02 per share	179.54	$0.35 per share	9.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALM Almonty Industries	-$115.88M	$0.16	55.57	6.17	N/A	125.89%	9.19%	3.97%	N/A
CGEM Cullinan Therapeutics	-$219.88M	-$3.10	N/A	N/A	N/A	N/A	-52.89%	-48.18%	11/5/2026 (Estimated)
KOPN Kopin	$2.61M	$0.04	84.90	N/A	N/A	18.26%	14.79%	8.42%	11/11/2026 (Estimated)

Latest ALM, KOPN, and CGEM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/11/2026	Q3 2026	KOPN Kopin	-$0.0060	N/A	N/A	N/A	$15.96 million	N/A
11/5/2026	Q3 2026	CGEM Cullinan Therapeutics	-$0.8435	N/A	N/A	N/A	$2.00 million	N/A
8/6/2026	Q2 2026	CGEM Cullinan Therapeutics	-$0.7993	-$0.81	-$0.0107	-$0.81	$3.67 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALM Almonty Industries	N/A	N/A	N/A	N/A	N/A
CGEM Cullinan Therapeutics	N/A	N/A	N/A	N/A	N/A
KOPN Kopin	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALM Almonty Industries	1.37	9.58	9.51
CGEM Cullinan Therapeutics	N/A	8.42	8.42
KOPN Kopin	N/A	2.18	2.05

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALM Almonty Industries	N/A
CGEM Cullinan Therapeutics	86.31%
KOPN Kopin	30.96%

Insider Ownership

Company	Insider Ownership
ALM Almonty Industries	N/A
CGEM Cullinan Therapeutics	8.60%
KOPN Kopin	2.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALM Almonty Industries	342	288.11 million	N/A	Optionable
CGEM Cullinan Therapeutics	109	64.36 million	58.82 million	Optionable
KOPN Kopin	145	185.87 million	181.04 million	Optionable

ALM, KOPN, and CGEM Headlines

Recent News About These Companies

Oppenheimer starts coverage with USD 7.00 target for Kopin stock

October 21, 2026 | ad-hoc-news.deA

Kopin Corporation (KOPN) Discusses the Trillion Dollar AI Interconnect Opportunity and Neural I/O in Next-Generation Data Centers Transcript

October 21, 2026 | seekingalpha.com

Kopin (NASDAQ:KOPN) Stock Jumps 7.1% - Still a Buy?

October 19, 2026 | marketbeat.com

Kopin Analysis Finds Optical Interconnect Architecture Could Break the Data Center "Copper Wall"

October 19, 2026 | tmcnet.com

Kopin Analysis Finds Optical Interconnect Architecture Could Break the Data Center “Copper Wall”

October 19, 2026 | businesswire.com

Kopin to Host Live YouTube "Ask Me Anything" Panel from Nasdaq MarketSite on the Future of AI Infrastructure

October 16, 2026 | businesswire.com

Kopin (NASDAQ:KOPN) Stock Price Down 7.5% - Should You Sell?

October 16, 2026 | marketbeat.com

Fabric.AI Announces Live AMA on AI Infrastructure Bottlenecks Featuring James Altucher, Kopin CEO Michael Murray and Cortney Harding

October 16, 2026 | quiverquant.comQ

Oppenheimer keeps USD 7.00 target for Kopin stock

October 16, 2026 | ad-hoc-news.deA

Analysts Offer Insights on Technology Companies: Kopin (KOPN), Tower (TSEM) and Zeta Global Holdings Corp (ZETA)

October 10, 2026 | theglobeandmail.com

Kopin (NASDAQ:KOPN) Shares Gap Up - Should You Buy?

October 9, 2026 | marketbeat.com

Stifel on Kopin Corp (KOPN): 'More Funding, More Displays, More Ways to Win'

October 9, 2026 | streetinsider.com

Kopin stock jumps on $18.6M Army display contract win

October 8, 2026 | au.finance.yahoo.com

Kopin Gets Additional $18.6 Million US Army Contract for Color MicroLED Technology

October 8, 2026 | finance.yahoo.com

Kopin receives additional $18.6M US Army contract

October 8, 2026 | msn.com

Kopin Secures Additional $18.6 Million U.S. Army IBAS Award for Color MicroLED Technology

October 8, 2026 | businesswire.com

Kopin (NASDAQ:KOPN) Stock Falls 8.6% - Here's What Happened

October 8, 2026 | marketbeat.com

Kopin to Introduce Expanded First‑Person Viewer Evaluation Kit Lineup at AUSA 2026

October 8, 2026 | businesswire.com

Kopin stock carries a USD 7.17 consensus target

October 6, 2026 | ad-hoc-news.deA

Stifel sets USD 6.50 target for Kopin stock

October 5, 2026 | ad-hoc-news.deA

Kopin Corporation (NASDAQ:KOPN) Stock Has Consensus Price Target of $7.17 According to Brokerages

October 2, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ALM, KOPN, and CGEM Company Descriptions

Almonty Industries NASDAQ:ALM

$9.16 +0.31 (+3.47%)

As of 12:04 PM Eastern

Almonty Industries Inc. is a producer of tungsten concentrate. The Company is currently mining, processing and shipping tungsten concentrate from its Panasqueira Mine in Portugal. Almonty Industries Inc. is based in TORONTO.

Cullinan Therapeutics NASDAQ:CGEM

$14.64 +0.27 (+1.86%)

As of 12:04 PM Eastern

Cullinan Therapeutics, Inc., a biopharmaceutical company, focuses on developing oncology therapies for cancer patients in the United States. The company's lead program comprises CLN-619, a monoclonal antibody that is in Phase I clinical trial for the treatment of solid tumors. Its development portfolio also includes CLN-049, a humanized bispecific antibody that is in Phase I clinical trial for the treatment of acute myeloid leukemia or myelodysplastic syndrome; CLN-418, a human bispecific immune activator that is in Phase 1 clinical trial for the treatment of multiple solid tumors; and Zipalertinib, a bioavailable small-molecule for treating patients with non-small cell lung cancer. In addition, the company's development products comprise CLN-617, a fusion protein for the treatment of solid tumors; and CLN-978, a T cell engaging antibody for the treatment relapsed/refractory B-cell non-Hodgkin lymphoma. It has license and collaboration agreement with Adimab, LLC to discover and/or optimize antibodies; Harbour BioMed US Inc. for the development, manufacturing, and commercialization of CLN-418; and co-development agreement with Taiho Pharmaceutical Co., Ltd to develop Zipalertinib. Cullinan Therapeutics, Inc. was formerly known as Cullinan Oncology, Inc. and changed its name to Cullinan Therapeutics, Inc. in April 2024. Cullinan Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Kopin NASDAQ:KOPN

$3.48 +0.10 (+2.81%)

As of 12:04 PM Eastern

Kopin Corporation, together with its subsidiaries, invents, develops, manufactures, and sells microdisplays, subassemblies, and related components for defense, enterprise, industrial, and consumer products in the United States, the Asia-Pacific, Europe, and internationally. It offers miniature active-matrix liquid crystal displays, liquid crystal on silicon displays/spatial light modulators, organic light emitting diode displays, microLED display technologies, application specific integrated circuits, backlights, and optical lenses; and head-mounted and hand-held VR products. The company's products are used for soldier thermal weapon rifle sights, avionic fixed and rotary wing pilot helmets, armored vehicle targeting systems, and training and simulation headsets; industrial and medical headsets; 3D optical inspection systems; and consumer augmented reality and virtual reality wearable headsets systems. Kopin Corporation was incorporated in 1984 and is headquartered in Westborough, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ALM, KOPN, and CGEM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ALM, KOPN, and CGEM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ALM, KOPN, and CGEM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ALM, KOPN, and CGEM Company Descriptions

Almonty Industries NASDAQ:ALM

Cullinan Therapeutics NASDAQ:CGEM

Kopin NASDAQ:KOPN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ALM, KOPN, and CGEM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ALM, KOPN, and CGEM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ALM, KOPN, and CGEM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ALM, KOPN, and CGEM Company Descriptions

Almonty Industries NASDAQ:ALM

Cullinan Therapeutics NASDAQ:CGEM

Kopin NASDAQ:KOPN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools